Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Genomics|January 25, 2025
CircPIK3C3 inhibits hepatocellular carcinoma progression and lenvatinib resistance by suppressing the Wnt/β-catenin pathway via the miR-452-5p/SOX15 axisFeng Yuan, Yongchang Tang, Hao Liang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 9, 2026
Dynamics changes of spleen volume predict survival outcomes in unresectable hepatocellular carcinoma treated with tislelizumab plus lenvatinibQingxun Zhou, Zhiyong Xiong, Hao Liang, et al.
Molecular Pharmaceutics|April 22, 2021
Quantification of P-Glycoprotein in the Gastrointestinal Tract of Humans and Rodents: Methodology, Gut Region, Sex, and Species MatterYang Mai, Liu Dou, Zhicheng Yao, et al.
Scientific Reports|July 3, 2025
Machine learning-assisted multi-dimensional transcriptomic analysis of cytoskeleton-related molecules and their relationship with prognosis in hepatocellular carcinomaYuxuan Li, Mingbo Cao, Xiaorui Su, et al.
Nature Communications|December 11, 2021
The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progressionXinzhi Li, Bingchuan Yuan, Min Lu, et al.
Molecular Oncology|February 18, 2017
ZKSCAN1 gene and its related circular RNA (circZKSCAN1) both inhibit hepatocellular carcinoma cell growth, migration, and invasion but through different signaling pathwaysZhicheng Yao, Jingyan Luo, Kunpeng Hu, et al.
Scientific Reports|March 19, 2025
The dietary patterns of water deer recently rediscovered in Northeast China exhibit remarkable similarities to those observed in other regionsZongzhi Li, Zhicheng Yao, Mingchun Zhang, et al.
International Journal of Biological Sciences|August 11, 2023
Lnc-ZEB2-19 Inhibits the Progression and Lenvatinib Resistance of Hepatocellular Carcinoma by Attenuating the NF-κB Signaling Pathway through the TRA2A/RSPH14 AxisMingbo Cao, Yupeng Ren, Yuxuan Li, et al.
Critical Reviews in Oncology/Hematology|April 19, 2025
Post-treatment adverse events ranking in targeted immunotherapy for hepatocellular carcinoma: A network meta-analysis based on risk probability assessmentGaoyuan Yang, Yupeng Ren, Yuxuan Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 15, 2025
CircRNA-mTOR Promotes Hepatocellular Carcinoma Progression and Lenvatinib Resistance Through the PSIP1/c-Myc AxisYongchang Tang, Feng Yuan, Mingbo Cao, et al.
Pageof 11